Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
-
* Corresponding author: Nouri Neamati neamati@usc.edu
Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, Los Angeles, CA 90089, USA
Retrovirology 2009, 6:25 doi:10.1186/1742-4690-6-25
Published: 5 March 2009Additional files
Additional file 1:
Table S1. Classification, activity, and pharmacokinetic data for IN inhibitory compounds described herein.
Format: DOC Size: 1.1MB Download file
This file can be viewed with: Microsoft Word Viewer
